Methyl 4-borono-3-chlorobenzoate is an aromatic boronic acid derivative characterized by a methyl ester group at the para position and a chlorine atom at the meta position relative to the boronic acid functional group. This compound serves as a versatile and valuable building block in organic synthesis, particularly in Suzuki-Miyaura cross-coupling reactions. The boronic acid group enables efficient carbon-carbon bond formation with various aryl or vinyl halides, while the ester and chloro substituents provide handles for further synthetic transformations. Its primary application is in the pharmaceutical industry as a key intermediate for the synthesis of active pharmaceutical ingredients (APIs) and complex drug candidates. The specific substitution pattern makes it useful for constructing biaryl systems and heterocyclic scaffolds found in many therapeutic agents. Research publications and chemical supplier catalogs list it specifically as a synthetic intermediate, highlighting its role in medicinal chemistry programs for developing new drug molecules. As a bench-stable solid, it requires standard handling precautions for boronic acids and should be stored under inert conditions to prevent deboronation. It is commercially available from major suppliers of fine chemicals and advanced intermediates for research and development purposes.